NA
TMDX icon

NewEdge Advisors’s Transmedics TMDX Stock Holding History

NewEdge Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.5K Sell
126
-69
-35% -$9K ﹤0.01% 3335
2025
Q4 		$23.7K Hold
195
– – ﹤0.01% 3195
2025
Q3 		$21.9K Sell
195
-11,117
-98% -$1.3M ﹤0.01% 3096
2025
Q2 		$1.52M Sell
11,312
-11,980
-51% -$1.32M 0.01% 1065
2025
Q1 		$1.57M Sell
23,292
-1,343
-5% -$92.4K 0.01% 967
2024
Q4 		$1.54M Buy
24,635
+11,406
+86% +$1.06M 0.01% 947
2024
Q3 		$2.08M Buy
13,229
+2,857
+28% +$440K 0.01% 779
2024
Q2 		$1.56M Buy
10,372
+2,140
+26% +$257K 0.01% 864
2024
Q1 		$609K Buy
8,232
+7,087
+619% +$584K 0.01% 1230
2023
Q4 		$90.4K Buy
1,145
+71
+7% +$4.28K ﹤0.01% 1984
2023
Q3 		$58.8K Sell
1,074
-545
-34% -$39.2K ﹤0.01% 2043
2023
Q2 		$136K Sell
1,619
-10,029
-86% -$768K ﹤0.01% 1755
2023
Q1 		$882K Sell
11,648
-3,708
-24% -$256K 0.01% 836
2022
Q4 		$35.6K Buy
15,356
+664
+5% +$35.3K ﹤0.01% 1868
2022
Q3 		$613K Buy
+14,692
New +$639K 0.01% 873

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Advisors's TMDX Position: Q1 2026 in Review

NewEdge Advisors reduced its Transmedics (TMDX) stake by 35% in Q1 2026, selling an estimated $9K and leaving 126 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3335.

NewEdge Advisors first reported a position in TMDX in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.08M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • NewEdge Advisors held 126 shares of Transmedics worth $12.5K as of Q1 2026.
  • NewEdge Advisors sold 69 Transmedics shares in Q1 2026, an estimated $9K.
  • Transmedics made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3335 holding.
  • NewEdge Advisors first reported a position in Transmedics in Q3 2022 and has held it in 15 quarters since.
  • NewEdge Advisors's Transmedics position peaked at $2.08M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.